Nodetrip
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nodetrip, covering 2021-06-22 to 2021-06-22. Get the full timeline:
Most recent: EMA Withdrawn: Nodetrip (previously Xeristar) (duloxetine) — Esteve Pharmaceuticals, S.A.